 BOSTON and JERUSALEM, Aug. 23, 2021 GLOBE NEWSWIRE -- Entera Bio Ltd. NASDAQ: ENTX, a leader in the development of orally delivered large molecule therapeutics, today announced the Companys CEO Spiros Jamas will present at the H.C. Wainwright 23rd Annual Global Investment Conference on Monday, September 13, 2021 at 3:30 pm ET at the Lotte New York Palace Hotel. The hybrid in-person and virtual conference will take place from September 1315, 2021. In addition to the presentation, management will conduct 1-on-1 meetings with investors. For more information on the conference or to register, visit: HCW Events. 